Many patients use cannabis to manage their cancer-related symptoms. However, research indicates that patients often do so without speaking to their oncologist first, and oncologists may be hesitant to ...
Smoking marijuana can increase cavities, tooth loss and the risk of oral cancers — but you can take steps to protect yourself.
As marijuana legalization has expanded to many states in the United States, understanding the full impact of cannabis use on patients experiencing health issues, including cancer, has gained new ...
Live Science on MSN
Can cannabis raise the risk of cancer?
Scientists are piecing together how cannabis smoke may disarm the body's immune arsenal while activating cancer-linked pathways. But the potential links aren't yet completely understood.
The findings could one day pave the way for new adjunct therapies that support both treatment effectiveness and patient quality of life. Two compounds found in cannabis show potent anti-tumor effects ...
It sounds like the stuff of pipe dreams, but for the past two decades, a handful of scientists around the world have been investigating the tumor-fighting properties of cannabis or, more specifically, ...
In a recent article published in the BMJ Supportive & Palliative Care journal, researchers presented the findings of the Quebec Cannabis Registry (QCR), a multicenter trial evaluating the ...
Researchers from Oregon Health and Science University announced new findings that cannabis products with high amounts of THC ...
Compounds in marijuana including THC and CBD show “promising potential as anticancer agents,” according to a recent review of scientific literature. The review by an international team of researchers ...
When it comes to treating ovarian cancer, existing drugs are often limited in effectiveness and can cause significant side effects, underscoring the need for new options. In response, researchers are ...
MedPage Today on MSN
GLP-1s and obesity cancers; cannabis' new legal status; celebrity cancer diagnoses
The FDA granted accelerated approval for the subcutaneous formulation of mosunetuzumab (Lunsumio VELO) for certain patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results